Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo - Wikidata - wikimedia - TriplyDB

Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo

Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo

http://www.wikidata.org/entity/Q33784923

about

Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and E Macrophages and cytokines in the early defence against herpes simplex virus Complement System Part II: Role in Immunity A Genomic Approach to Unravel Host-Pathogen Interaction in Chelonians: The Example of Testudinid Herpesvirus 3 Infections of People with Complement Deficiencies and Patients Who Have Undergone Splenectomy Nod1 signaling overcomes resistance of S. pneumoniae to opsonophagocytic killing.Murine gammaherpesvirus 68 encodes a functional regulator of complement activation Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant.Herpes simplex virus type 1 glycoprotein E domains involved in virus spread and disease HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.Complement and viral pathogenesis Herpes simplex virus vectors elicit durable immune responses in the presence of preexisting host immunity.Herpes simplex virus type 1 and 2 glycoprotein C prevents complement-mediated neutralization induced by natural immunoglobulin M antibody.Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humans The herpes simplex virus 1 IgG fc receptor blocks antibody-mediated complement activation and antibody-dependent cellular cytotoxicity in vivo.Herpes simplex virus 2 (HSV-2) infected cell proteins are among the most dominant antigens of a live-attenuated HSV-2 vaccine.ICP22 is required for wild-type composition and infectivity of herpes simplex virus type 1 virions.Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compa Live attenuated herpes simplex virus 2 glycoprotein E deletion mutant as a vaccine candidate defective in neuronal spread.In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gC Dissection of functional sites in herpesvirus saimiri complement control protein homolog.Humoral response to herpes simplex virus is complement-dependent.Herpes simplex virus type 1 ICP27 regulates expression of a variant, secreted form of glycoprotein C by an intron retention mechanism.Towards an effective genital herpes vaccine: past lessons and future prospects.Blocking immune evasion as a novel approach for prevention and treatment of herpes simplex virus infection Immune responses to herpesviral vectors.Neuraminidase-mediated, NKp46-dependent immune-evasion mechanism of influenza viruses.Immunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccine Herpes simplex virus as a tool to define the role of complement in the immune response to peripheral infection.Widely Used Herpes Simplex Virus 1 ICP0 Deletion Mutant Strain dl1403 and Its Derivative Viruses Do Not Express Glycoprotein C Due to a Secondary Mutation in the gC Gene Hexamethylene bisacetamide leads to reduced helper virus-free HSV-1 amplicon expression titers via suppression of ICP0.Virus inhibition of RIP3-dependent necrosis.Cell surface expression of the vaccinia virus complement control protein is mediated by interaction with the viral A56 protein and protects infected cells from complement attack.Identification and characterization of duck plague virus glycoprotein C gene and gene product.Structural rearrangement within an enveloped virus upon binding to the host cell.DNA vaccine expressing herpes simplex virus 1 glycoprotein C and D protects mice against herpes simplex keratitis.Herpesviruses: Harmonious Pathogens but Relevant Cofactors in Other Diseases?

P2860

Q24646778-1173957E-1FB1-4D71-B0D9-D9C62048441D Q24815062-20FB9B57-8B73-40CB-94A9-C077133B8FFE Q28263460-3DDBDE29-9DFF-4687-BE17-32766F119499 Q28645221-3BEFB975-3F9A-4628-9B40-05F865691E5D Q28972389-F1FB4051-7E94-4AC8-AB75-765628B8D10C Q33295217-89C6A1C1-7016-4E1A-94D3-78A0FA49DF7C Q33650182-B94A3A04-BCA6-491C-8848-EE7348B3624E Q33804845-A03C12B6-4266-404F-9082-46B8967013C1 Q33808376-96F1DED1-C2F2-4078-87A9-966EEFF08E52 Q33995747-0A22B0F7-3269-48D0-9291-046799A6C877 Q34162421-67EFD3A4-88AC-4B25-88CC-DE7FDF332FC7 Q34335296-565BCFA3-6EE9-4BF0-B8C2-D02A3BBA76F4 Q34545821-00DEFA9A-87BF-4C4A-BD9F-B79500B566A3 Q34593833-03173ACC-23D5-44FD-BA42-38E40922BDFF Q34742635-A756F12A-8630-474A-A24D-FD8D2F023A6F Q35058245-B9747319-3319-43CC-8594-4B15FA015077 Q35101439-257315C5-A883-4647-8F60-5F516B5BC43D Q35275146-2A61B7C1-B13A-4202-A6F1-6FC0242D3532 Q35867958-3D2CCF09-C46F-43A4-9EB8-A6CFD8310B2A Q36375668-FF878622-97E6-4CB5-935F-69F39B08DD2C Q36506856-9A91C1AC-1FE8-4211-96B9-6A84AA9A2F1A Q36552488-3057CF75-B19B-4E0F-90EC-6733D4ACC0B3 Q36804576-B2D5D8C8-7D57-4C4B-8593-E31849BFCB0C Q36991575-5673E8FF-85B7-4DF9-8685-79BBE56F0F29 Q37060288-CD25FA41-C4D0-45FC-87F9-BC9687A33F84 Q37392882-CE8F6F04-0091-48A3-B82C-EDAAF1EBF6F1 Q37394308-97EEFD02-68D3-4E77-9A94-10F594759571 Q37439603-38EE62CF-5BDE-4E5B-95B4-0514D0BC78C1 Q37456642-D408C96B-10EE-4405-B0B1-8DCD8E06FC2F Q38851826-EE7F2A3E-53DE-4BE1-95F3-407A60DEF34C Q39601616-A006C9AE-13E6-4167-83E3-E027AB3F100D Q39711744-37D714BA-48DA-42A5-9D66-248B55F92969 Q40011089-802A55B4-0EBA-4B78-83E9-F425FBD8BB1C Q41253220-7FFE5444-24A4-48D5-9710-F095C0361666 Q43007482-4AEBD401-4F39-476A-814E-7D3EF99C2552 Q45324169-52676390-EC41-4062-80FF-490AC0658668 Q55397851-09A28F24-2A3D-49D3-979A-9300716700E1

P2860

Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo

http://www.wikidata.org/entity/Q33784923

description

1998 nî lūn-bûn

@nan

1998 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo

@ast

Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo

@en

type

label

Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo

@ast

Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo

@en

prefLabel

Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo

@ast

Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo

@en

P1433

Q33784923-B737BB55-7DD2-4997-8C77-9E7E11DAE23F

P1476

Q33784923-8CA6C09D-1832-431E-BDDD-7CBD89CC2859

P2093

Q33784923-4729292F-6966-4243-80FC-C8E65C606663

Q33784923-494B1ECD-1D9B-4BA6-B68E-1EC51A6087AD

Q33784923-5748B207-709E-4704-9B20-C74F29046A68

Q33784923-63B5C4A9-2E91-4ABB-ABA2-970150EB4D4E

Q33784923-7CB9F966-6278-4401-8B47-199F8C5358B6

Q33784923-81BAA68D-D8A4-4477-9A24-C0F9C1AAEDC2

Q33784923-86A26393-5DB8-43CF-BDDF-47450D08CD65

Q33784923-87034710-4892-448D-9DEA-3F7D197508B1

Q33784923-C5284AF0-B267-46AE-B9BF-DB7D12B1F158

Q33784923-D5082AC3-1BDE-4D77-A808-5A56DB691AD9

P2860

Q33784923-02C38373-3EC4-43D5-B2BB-D8688E9BFBB1

Q33784923-065AA850-BA89-4D75-9F1B-C23193331484

Q33784923-0B0A59CC-BD77-4600-A6C7-35DCCB315ED8

Q33784923-0F4DFE33-2720-4DC5-A242-100B4F579852

Q33784923-1105F8B2-A542-4CDE-8E2F-6931098B53BA

Q33784923-13331AC1-0605-4A09-A3BB-51C3DD474604

Q33784923-206B2F1E-BBDD-48CC-94B5-3E6D64635B79

Q33784923-28563764-B061-4A67-BFAB-354C4DC67897

Q33784923-349AC34D-EC80-4847-9534-F1018452ABB9

Q33784923-366897F4-9A6E-4042-BE1A-CE0A89B0C3A0

P304

Q33784923-07928748-FEBF-499E-AFFF-E2544917524E

P31

Q33784923-9FA4B883-23AA-4048-9076-354B7E4A524F

P433

Q33784923-F6C7354E-EA69-4690-A778-04D527AA8530

P478

Q33784923-C9A7155F-B467-47C6-9468-7A2A9FF071EC

P577

Q33784923-A0C64DEE-6B23-43FE-B216-7C3DFA2A19A4

P698

Q33784923-B8FEB93C-077E-49D4-90B1-97BF3E82BCEE

P932

Q33784923-7060BEF8-B7A3-49B4-832B-ECF8D04F6A6B

P1433

Journal of Virology

P1476

Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo

@en

P2093

A M Soulika

http://www.w3.org/2001/XMLSchema#string

G H Cohen

http://www.w3.org/2001/XMLSchema#string

H Colten

http://www.w3.org/2001/XMLSchema#string

H M Friedman

http://www.w3.org/2001/XMLSchema#string

J D Lambris

http://www.w3.org/2001/XMLSchema#string

J M Lubinski

http://www.w3.org/2001/XMLSchema#string

L Wang

http://www.w3.org/2001/XMLSchema#string

R A Wetsel

http://www.w3.org/2001/XMLSchema#string

R Burger

http://www.w3.org/2001/XMLSchema#string

R J Eisenberg

http://www.w3.org/2001/XMLSchema#string

P2860

Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity

In vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobulin G Fc receptor.

Binding of complement component C3b to glycoprotein gC of herpes simplex virus type 1: mapping of gC-binding sites and demonstration of conserved C3b binding in low-passage clinical isolates

Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses.

Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules

Immune evasion properties of herpes simplex virus type 1 glycoprotein gC.

Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.

Ocular disease pattern induced by herpes simplex virus is genetically determined by a specific region of viral DNA.

Epstein-Barr virus regulates activation and processing of the third component of complement.

Type-common CP-1 antigen of herpes simplex virus is associated with a 59,000-molecular-weight envelope glycoprotein

P304

8257-8263

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P577

1998-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9733869

http://www.w3.org/2001/XMLSchema#string

P932

110183

http://www.w3.org/2001/XMLSchema#string